Provided by Tiger Trade Technology Pte. Ltd.

Acumen Pharmaceuticals, Inc.

3.06
-0.0150-0.49%
Volume:208.87K
Turnover:649.12K
Market Cap:220.97M
PE:-1.87
High:3.17
Open:3.09
Low:3.04
Close:3.08
52wk High:3.60
52wk Low:1.21
Shares:72.21M
Float Shares:37.05M
Volume Ratio:0.51
T/O Rate:0.56%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6370
EPS(LYR):-2.0035
ROE:-120.50%
ROA:-45.77%
PB:3.86
PE(LYR):-1.53

Loading ...

ProMIS Neurosciences Q2 Net Loss Widens

Reuters
·
Aug 14

Citi Remains a Buy on Acumen Pharmaceuticals (ABOS)

TIPRANKS
·
Aug 13

Acumen Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 12

Acumen Pharmaceuticals Posts Corporate Presentation on Sabirnetug Antibody Program for Early Alzheimer’s Disease

Reuters
·
Aug 12

Acumen Pharmaceuticals Q2 EPS $(0.45) Misses $(0.34) Estimate

Benzinga Earnings
·
Aug 12

Acumen Pharmaceuticals Q2 Net Loss Widens, Misses Analyst Estimates

Reuters
·
Aug 12

Acumen Pharmaceuticals, Inc. Q2 Income from Operations USD -32.556 Million Vs. IBES Estimate USD -24.6 Million

Reuters
·
Aug 12

Acumen Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Highlights

THOMSON REUTERS
·
Aug 12

Acumen Pharmaceuticals, Inc. Q2 Basic EPS USD -0.45

THOMSON REUTERS
·
Aug 12

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Aug 11

Acumen Pharmaceuticals Inc Expected to Post a Loss of 37 Cents a Share - Earnings Preview

Reuters
·
Aug 10

Acumen Pharmaceuticals Inc Expected to Post a Loss of 37 Cents a Share - Earnings Preview

Reuters
·
Aug 08

Acumen Pharmaceuticals to Report Second Quarter Financial Results on August 12, 2026

GlobeNewswire
·
Aug 06

Acumen presents new findings at AAIC conference

TIPRANKS
·
Jul 15

Acumen Says EBD Candidate Acu401 Boosts Brain Exposure up to 40-fold in Primate Study

Reuters
·
Jul 15

Acumen Pharmaceuticals - Ebd Bispecific Antibodies Show Improved Brain Penetration Compared to Native Anti-aβo Antibodies

THOMSON REUTERS
·
Jul 15

Acumen Pharmaceuticals - no Hematological Safety Signals Observed for Acu401 in Non-human Primates

THOMSON REUTERS
·
Jul 15

Acumen Pharmaceuticals Highlights Enhanced Brain Delivery™ (EBD™) Program Data and Early Alzheimer’s Disease Insights at the Alzheimer’s Association International Conference (AAIC®) 2026

GlobeNewswire
·
Jul 15

Acumen Pharmaceuticals to Present Enhanced Brain Delivery Alzheimer’s Data at AAIC 2026

Reuters
·
Jul 07

Acumen Pharmaceuticals Insider Makes Eye-Catching Stock Move

TIPRANKS
·
Jun 18